中国中免：公司生产经营正常，无应披露而未披露的重大事项

Core Viewpoint - China National Pharmaceutical Group announced that its A-share stock price has deviated by more than 20% over three consecutive trading days, indicating abnormal trading fluctuations [1] Group 1 - The company conducted a self-examination and confirmed that neither it nor its controlling shareholder has undisclosed significant information, including major asset restructuring or share issuance [1] - The company's daily operations are normal and orderly, with no significant changes reported [1] - The short-term volatility of the company's stock price is considerable, prompting a cautionary note for investors regarding secondary market trading risks and the importance of rational decision-making [1]